20 October 2017
News and Views
Links and Services
A study in August's issue of the Alimentary Pharmacology & Therapeutics evaluated the factors associated with relapse of IBD after discontinuation of anti-TNF therapy.
The discontinuation of anti-tumour necrosis factor (anti-TNF) treatment in inflammatory bowel dis
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors